These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4800851)

  • 1. A new principle for the comparison of insulin secretory responses. I. The effect of age on insulin secretion.
    Johansen K
    Acta Endocrinol (Copenh); 1973 Nov; 74(3):511-23. PubMed ID: 4800851
    [No Abstract]   [Full Text] [Related]  

  • 2. A new principle for the comparison of insulin secretory responses. II. The effect of obesity on insulin secretion.
    Johansen K
    Acta Endocrinol (Copenh); 1973 Nov; 74(3):524-41. PubMed ID: 4800852
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasma insulin levels in endocrine diseases. I. Plasma insulin levels in normal subjects and diabetic patients].
    Ikeda M
    Nihon Naibunpi Gakkai Zasshi; 1971 Aug; 47(5):282-90. PubMed ID: 5106320
    [No Abstract]   [Full Text] [Related]  

  • 4. The spectrum of plasma insulin responses in middle-aged and old non-obese diabetics with various degrees of metabolic derangement.
    Johansen K
    Acta Med Scand; 1973; 194(3):157-64. PubMed ID: 4746522
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous glucose tolerance and early insulin response. Studies on a random sample of women aged 50 and patients with diabetes mellitus.
    Blohmé G
    Acta Med Scand Suppl; 1974; 566():1-121. PubMed ID: 4533586
    [No Abstract]   [Full Text] [Related]  

  • 6. Basal and stimulated insulin levels: comparison of insulinogenic effects of oral glucose and intravenous tolbutamide in nondiabetic and diabetic subjects.
    Bagdade JD; Bierman EL; Porte D
    Metabolism; 1971 Nov; 20(11):1000-7. PubMed ID: 5115750
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum immunoreactive insulin response to oral glucose and intravenous sodium tolbutamide administration in relation to obesity.
    Devrim S; Koniçe M; Sencer E; Molvalìlar S; Alp H
    Isr J Med Sci; 1972 Jun; 8(6):815-20. PubMed ID: 5051802
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on low insulin responders. Glucose tolerance and insulin response to intravenous and oral glucose challenges in 226 normal subjects and 25 subjects with mild or chemical diabetes.
    Efendić S; Cerasi E; Elander I; Thornqvist C; Fick G; Berglund B; Luft R
    Acta Endocrinol Suppl (Copenh); 1979; 224():5-32. PubMed ID: 285561
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.
    Barnes AJ; Garbien KJ; Crowley MF; Bloom A
    Lancet; 1974 Jul; 2(7872):69-72. PubMed ID: 4136696
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 11. Maximum stimulation of insulin secretion in children with chemical diabetes and obesity.
    Castells S; Avruskin T; Reddy CM; Hashemi SE
    Am J Med Sci; 1976; 271(1):35-9. PubMed ID: 943938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin response to glucose and tolbutamide in "essential" versus "pancreatic" mild glucose intolerance.
    Vague P; Ramahandridona G; Gerolami A
    Diabetes; 1974 Nov; 23(11):896-901. PubMed ID: 4430416
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies in prediabetes. Insulin response to oral glucose, intravenous tolbutamide and rapid intravenous glucose infusion in genetic prediabetics.
    Serrano-Rios M; Ramos F; Rodriguez-Miñon JL; Vivanco F
    Diabetologia; 1970 Aug; 6(4):392-8. PubMed ID: 5456764
    [No Abstract]   [Full Text] [Related]  

  • 14. Abnormal serum growth hormone responses in genetically potential-diabetic male patients with normal oral glucose tolerance: evidence for an insulin-like action of growth hormone in vivo.
    Sönksen PH; Soeldner JS; Gleason RE; Boden G
    Diabetologia; 1973 Oct; 9(5):426-37. PubMed ID: 4773203
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin response to glucose, tolbutamide, secretin, and isoprenaline in maturity-onset diabetes mellitus.
    Deckert T; Lauridsen UB; Madsen SN; Mogensen P
    Dan Med Bull; 1972 Oct; 19(7):222-6. PubMed ID: 5079926
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative studies of the oral and intravenous tolbutamide test. II. Determination of glucose, serum-insulin and serum-tolbutamide in normal young subjects].
    Berchtold P; Büber V; Meier V; Felber JP; Keiser G
    Diabetologia; 1971 Apr; 7(2):77-81. PubMed ID: 5581543
    [No Abstract]   [Full Text] [Related]  

  • 17. Diurnal variation in glucose tolerance and in insulin secretion in man.
    Carroll KF; Nestel PJ
    Diabetes; 1973 May; 22(5):333-48. PubMed ID: 4700047
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of short-term tolbutamide treatment on insulin dynamics in newly diagnosed obese and non-obese adult diabetics.
    Wajchenberg BL; Nakasone K; Pasternak K
    Horm Metab Res; 1970 Jan; 2(1):6-8. PubMed ID: 5520756
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on insulinemia in parents of diabetic children].
    Szybiński Z; Sieradzki J; Mruk K; Golda W
    Przegl Lek; 1973; 30(5):441-7. PubMed ID: 4723332
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma-insulin after tolbutamide in diabetics and non-diabetics.
    Deckert T; Mogensen P
    Acta Med Scand; 1970 Apr; 187(4):309-12. PubMed ID: 5447096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.